Intervention
Epinephrine
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 8 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
8 shownRegional Lipolysis and Adipocyte Lipolysis Protein StimulationNCT06416969 · 2024-01-01
RECRUITINGVasoactive Drugs in Intensive Care UnitNCT02118467 · 2014-05-15
RECRUITINGVasopressor Agents in Pulmonary Hypertension CrisisNCT07667829 · 2026-06-01
NOT_YET_RECRUITINGM7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung CancersNCT03554473 · 2018-09-11
COMPLETEDDose Response of EpinephrineNCT02692313 · 2016-06-01
COMPLETEDManagement of Acute Pulmonary Hypertensive Crisis in Children With Known Pulmonary Arterial HypertensionNCT05439460 · 2012-01-01
COMPLETEDTrial of Vasopressin and Epinephrine to Epinephrine Only for In-Hospital Pediatric Cardiopulmonary ResuscitationNCT00628550 · 2008-04-01
COMPLETEDMechanisms of Hypoglycemia Associated Autonomic FailureNCT00678145 · 2008-03-01
TERMINATEDCommon conditions
Autonomic Failure1Carcinoma, Small Cell1Cardiac Arrest1Cardiopulmonary Arrest1Chronic Thromboembolic Pulmonary Hypertension (CTEPH)1Diabetes Complications1Diabetes Mellitus1Hypertension, Pulmonary1Hypoglycemia1Lung Cancer1Obesity1Pulmonary Arterial Hypertension1Pulmonary Arterial Hypertension (PAH)1Shock1Small Cell Lung Cancer1
Leading sponsors
Trial status mix
COMPLETED4
RECRUITING2
NOT_YET_RECRUITING1
TERMINATED1
Phase mix
EARLY_PHASE12
PHASE12
PHASE22
PHASE42
NA1
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.